173 related articles for article (PubMed ID: 7542233)
1. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding.
Juan TS; Hailman E; Kelley MJ; Wright SD; Lichenstein HS
J Biol Chem; 1995 Jul; 270(29):17237-42. PubMed ID: 7542233
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS.
Juan TS; Kelley MJ; Johnson DA; Busse LA; Hailman E; Wright SD; Lichenstein HS
J Biol Chem; 1995 Jan; 270(3):1382-7. PubMed ID: 7530712
[TBL] [Abstract][Full Text] [Related]
3. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64.
Juan TS; Hailman E; Kelley MJ; Busse LA; Davy E; Empig CJ; Narhi LO; Wright SD; Lichenstein HS
J Biol Chem; 1995 Mar; 270(10):5219-24. PubMed ID: 7534291
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
Kitchens RL; Ulevitch RJ; Munford RS
J Exp Med; 1992 Aug; 176(2):485-94. PubMed ID: 1380063
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14.
Han J; Mathison JC; Ulevitch RJ; Tobias PS
J Biol Chem; 1994 Mar; 269(11):8172-5. PubMed ID: 7510680
[TBL] [Abstract][Full Text] [Related]
6. A region of human CD14 required for lipopolysaccharide binding.
Viriyakosol S; Kirkland TN
J Biol Chem; 1995 Jan; 270(1):361-8. PubMed ID: 7529231
[TBL] [Abstract][Full Text] [Related]
7. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells.
Read MA; Cordle SR; Veach RA; Carlisle CD; Hawiger J
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9887-91. PubMed ID: 7694295
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.
Tobias PS; Soldau K; Gegner JA; Mintz D; Ulevitch RJ
J Biol Chem; 1995 May; 270(18):10482-8. PubMed ID: 7537731
[TBL] [Abstract][Full Text] [Related]
9. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide.
McGinley MD; Narhi LO; Kelley MJ; Davy E; Robinson J; Rohde MF; Wright SD; Lichenstein HS
J Biol Chem; 1995 Mar; 270(10):5213-8. PubMed ID: 7534290
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.
Pugin J; Schürer-Maly CC; Leturcq D; Moriarty A; Ulevitch RJ; Tobias PS
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2744-8. PubMed ID: 7681988
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.
Wurfel MM; Hailman E; Wright SD
J Exp Med; 1995 May; 181(5):1743-54. PubMed ID: 7536794
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.
Hailman E; Lichenstein HS; Wurfel MM; Miller DS; Johnson DA; Kelley M; Busse LA; Zukowski MM; Wright SD
J Exp Med; 1994 Jan; 179(1):269-77. PubMed ID: 7505800
[TBL] [Abstract][Full Text] [Related]
13. Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein.
Tapping RI; Tobias PS
J Biol Chem; 1997 Sep; 272(37):23157-64. PubMed ID: 9287319
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide.
Dziarski R; Viriyakosol S; Kirkland TN; Gupta D
Infect Immun; 2000 Sep; 68(9):5254-60. PubMed ID: 10948152
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis for therapeutic concepts utilizing CD14.
Stelter F; Bernheiden M; Menzel R; Witt S; Jack RS; Grunwald U; Fan X; Schütt C
Prog Clin Biol Res; 1998; 397():301-13. PubMed ID: 9575571
[TBL] [Abstract][Full Text] [Related]
16. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS
J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028
[TBL] [Abstract][Full Text] [Related]
17. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.
Lee JD; Kato K; Tobias PS; Kirkland TN; Ulevitch RJ
J Exp Med; 1992 Jun; 175(6):1697-705. PubMed ID: 1375269
[TBL] [Abstract][Full Text] [Related]
18. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide.
Haziot A; Rong GW; Silver J; Goyert SM
J Immunol; 1993 Aug; 151(3):1500-7. PubMed ID: 7687634
[TBL] [Abstract][Full Text] [Related]
19. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity.
Theofan G; Horwitz AH; Williams RE; Liu PS; Chan I; Birr C; Carroll SF; Mészáros K; Parent JB; Kasler H
J Immunol; 1994 Apr; 152(7):3623-9. PubMed ID: 7511654
[TBL] [Abstract][Full Text] [Related]
20. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
Wright SD; Ramos RA; Tobias PS; Ulevitch RJ; Mathison JC
Science; 1990 Sep; 249(4975):1431-3. PubMed ID: 1698311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
